Online For Alumni For Clergy For Students General Audience Credit Offered

Dr. Aasim Padela will discuss the foundations of Islamic bioethical discourse based on the various moral sciences of the Islamic tradition. He will further touch upon aspects of the discourse in orienting the audience to its siloed nature. The talk will conclude with a discussion on how an Islamic bioethics may intersect with academic bioethics as a field.

Speaker

Aasim Padela
Aasim Padela, M.D., M.Sc.
Professor & Vice Chair of Research, Emergency Medicine; Professor of Bioethics & Medical Humanities, Medical College of Wisconsin

Dr. Aasim Padela is an emergency medicine physician and an academic scholar with research foci at the intersection of bioethics, public health, and religion. Overall, his scholarship aims to advance health equity and societal well-being through multidisciplinary inquiry and multilevel intervention. 

Dr. Padela’s expertise spans a variety of research methodologies and topics, including community-engaged, patient-centered, and human-centered research design, behavior change theory, religiously tailored and faith-based messaging, survey and qualitative research, discourse analysis, character education, clinical ethics, and Islamic theology. 

Dr. Padela holds an M.D. from Weill Cornell Medical College and an M.Sc. in Healthcare Research from the University of Michigan. He also holds a B.S. in biomedical engineering and a B.A. in classical Arabic from the University of Rochester. He completed emergency medicine training at the University of Rochester, a research fellowship at the University of Michigan, a clinical medical ethics fellowship at the MacLean Center for Clinical Medical Ethics at the University of Chicago and visiting fellowships at the Oxford Centre for Islamic Studies and the International Institute for Islamic Thought. 

He has authored over 150 peer-reviewed articles and book chapters and one monograph, "Maqasid al-Shariah and Biomedicine: Bridging Moral, Ethical and Policy Discourses" (IIIT Press 2024).